Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-001479-22Phase 4Active
Phase 4 trial of norepinephrine and dobutamine in Cardiovascular collapse and cardiovascular dysfunction, sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Postoperative morbidity (primary). Started Jul 2017; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-001479-22.